{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:39:14Z","timestamp":1790095154686,"version":"4.0.1"},"reference-count":162,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health, National Cancer Institute","doi-asserted-by":"publisher","award":["CA250017"],"award-info":[{"award-number":["CA250017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Progress in the development of effective chemotherapy is producing a growing population of patients with acute and chronic painful chemotherapy-induced peripheral neuropathy (CIPN), a serious treatment-limiting side effect for which there is currently no US Food and Drug Administration-approved treatment.<\/jats:p>\n               <jats:p>CIPNs induced by diverse classes of chemotherapy drugs have remarkably similar clinical presentations, leading to the suggestion they share underlying mechanisms. Sensory neurons share with immune cells the ability to detect damage associated molecular patterns (DAMPs), molecules produced by diverse cell types in response to cellular stress and injury, including by chemotherapy drugs. DAMPs, in turn, are ligands for pattern recognition receptors (PRRs), several of which are found on sensory neurons, as well as satellite cells, and cells of the immune system. In the present experiments, we evaluated the role of two PRRs, TLR4 and RAGE, present in dorsal root ganglion (DRG), in CIPN.<\/jats:p>\n               <jats:p>Antisense (AS)-oligodeoxynucleotides (ODN) against TLR4 and RAGE mRNA were administered intrathecally before (\u2018prevention protocol\u2019) or 3\u2005days after (\u2018reversal protocol\u2019) the last administration of each of three chemotherapy drugs that treat cancer by different mechanisms (oxaliplatin, paclitaxel and bortezomib). TLR4 and RAGE AS-ODN prevented the development of CIPN induced by all three chemotherapy drugs. In the reversal protocol, however, while TLR4 AS-ODN completely reversed oxaliplatin- and paclitaxel-induced CIPN, in rats with bortezomib-induced CIPN it only produced a temporary attenuation. RAGE AS-ODN, in contrast, reversed CIPN induced by all three chemotherapy drugs.<\/jats:p>\n               <jats:p>When a TLR4 antagonist was administered intradermally to the peripheral nociceptor terminal, it did not affect CIPN induced by any of the chemotherapy drugs. However, when administered intrathecally, to the central terminal, it attenuated hyperalgesia induced by all three chemotherapy drugs, compatible with a role of TLR4 in neurotransmission at the central terminal but not sensory transduction at the peripheral terminal.<\/jats:p>\n               <jats:p>Finally, since it has been established that cultured DRG neurons can be used to study direct effects of chemotherapy on nociceptors, we also evaluated the role of TLR4 in CIPN at the cellular level, using patch-clamp electrophysiology in DRG neurons cultured from control and chemotherapy-treated rats. We found that increased excitability of small-diameter DRG neurons induced by in vivo and in vitro exposure to oxaliplatin is TLR4-dependent. Our findings suggest that in addition to the established contribution of PRR-dependent neuroimmune mechanisms, PRRs in DRG cells also have an important role in CIPN.<\/jats:p>","DOI":"10.1093\/brain\/awad339","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T20:33:54Z","timestamp":1696019634000},"page":"1025-1042","source":"Crossref","is-referenced-by-count":33,"title":["Role of pattern recognition receptors in chemotherapy-induced neuropathic pain"],"prefix":"10.1093","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8379-2901","authenticated-orcid":false,"given":"Dion\u00e9ia","family":"Araldi","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, UCSF Pain and Addiction Research Center, University of California at San Francisco , San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-2237","authenticated-orcid":false,"given":"Eugen V","family":"Khomula","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, UCSF Pain and Addiction Research Center, University of California at San Francisco , San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-3237","authenticated-orcid":false,"given":"Ivan J M","family":"Bonet","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, UCSF Pain and Addiction Research Center, University of California at San Francisco , San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-4413","authenticated-orcid":false,"given":"Oliver","family":"Bogen","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, UCSF Pain and Addiction Research Center, University of California at San Francisco , San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-6826","authenticated-orcid":false,"given":"Paul G","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, UCSF Pain and Addiction Research Center, University of California at San Francisco , San Francisco, CA 94143 , USA"},{"name":"Department of Preventative and Restorative Dental Sciences, Division of Neuroscience, University of California at San Francisco , San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0681-5545","authenticated-orcid":false,"given":"Jon D","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, UCSF Pain and Addiction Research Center, University of California at San Francisco , San Francisco, CA 94143 , USA"},{"name":"Department of Medicine, Division of Neuroscience, University of California at San Francisco , San Francisco, CA 94143 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"2024030122262487900_awad339-B1","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1007\/s00520-021-06042-x","article-title":"Chemotherapy-induced peripheral neuropathy (CIPN): Current therapies and topical treatment option with high-concentration capsaicin","volume":"29","author":"Maihofner","year":"2021","journal-title":"Support Care Cancer"},{"key":"2024030122262487900_awad339-B2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpainsymman.2016.12.342","article-title":"Chemotherapy-induced neuropathy in cancer survivors","volume":"54","author":"Miaskowski","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"2024030122262487900_awad339-B3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s43440-020-00109-y","article-title":"Chemotherapy-induced peripheral neuropathy: Part 1-current state of knowledge and perspectives for pharmacotherapy","volume":"72","author":"Salat","year":"2020","journal-title":"Pharmacol Rep"},{"key":"2024030122262487900_awad339-B4","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/biomedicines10081909","article-title":"Neuromodulation therapy for chemotherapy-induced peripheral neuropathy: A systematic review","volume":"10","author":"D'Souza","year":"2022","journal-title":"Biomedicines"},{"key":"2024030122262487900_awad339-B5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jamaneurol.2016.0383","article-title":"The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling","volume":"73","author":"Kolb","year":"2016","journal-title":"JAMA Neurol"},{"key":"2024030122262487900_awad339-B6","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00520-014-2255-7","article-title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life: A systematic review","volume":"22","author":"Mols","year":"2014","journal-title":"Support Care Cancer"},{"key":"2024030122262487900_awad339-B7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.12788\/jcso.0086","article-title":"Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy","volume":"12","author":"Beijers","year":"2014","journal-title":"J Community Support Oncol"},{"key":"2024030122262487900_awad339-B8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/jns.12097","article-title":"Long-term course of oxaliplatin-induced polyneuropathy: A prospective 2-year follow-up study","volume":"19","author":"Briani","year":"2014","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl 1","key":"2024030122262487900_awad339-B10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/j.pain.0000000000001540","article-title":"Chemotherapy-induced peripheral neuropathy: Where are we now?","volume":"160","author":"Colvin","year":"2019","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jama.2021.7458","article-title":"Recommendations for prevention and management of chemotherapy-induced peripheral neuropathy","volume":"326","author":"Derman","year":"2021","journal-title":"JAMA"},{"key":"2024030122262487900_awad339-B12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/15360288.2020.1734144","article-title":"Chemotherapy-induced peripheral neuropathy: Causative agents, preventative strategies, and treatment approaches","volume":"34","author":"Kachrani","year":"2020","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2024030122262487900_awad339-B13","doi-asserted-by":"crossref","first-page":"637593","DOI":"10.3389\/fphar.2021.637593","article-title":"Prevalence of chemotherapy-induced peripheral neuropathy in multiple myeloma patients and its impact on quality of life: A single center cross-sectional study","volume":"12","author":"Selvy","year":"2021","journal-title":"Front Pharmacol"},{"key":"2024030122262487900_awad339-B14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: A current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann Neurol"},{"key":"2024030122262487900_awad339-B15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2017.06.008","article-title":"Mechanisms and therapeutic relevance of neuro-immune communication","volume":"46","author":"Chavan","year":"2017","journal-title":"Immunity"},{"key":"2024030122262487900_awad339-B16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zajaczkowska","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024030122262487900_awad339-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: All we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J Leukoc Biol"},{"key":"2024030122262487900_awad339-B18","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: A double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"key":"2024030122262487900_awad339-B19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.trre.2011.02.003","article-title":"Emerging role of innate immunity in organ transplantation part II: Potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells","volume":"26","author":"Land","year":"2012","journal-title":"Transplant Rev (Orlando)"},{"key":"2024030122262487900_awad339-B20","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1111\/ajt.13963","article-title":"Transplantation and Damage-Associated Molecular Patterns (DAMPs)","volume":"16","author":"Land","year":"2016","journal-title":"Am J Transplant"},{"key":"2024030122262487900_awad339-B21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2007.08.004","article-title":"Inside, outside, upside down: Damage-associated molecular-pattern molecules (DAMPs) and redox","volume":"28","author":"Rubartelli","year":"2007","journal-title":"Trends Immunol"},{"key":"2024030122262487900_awad339-B22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-015-0239-2","article-title":"Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons","volume":"12","author":"Santoni","year":"2015","journal-title":"J Neuroinflammation"},{"key":"2024030122262487900_awad339-B23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.tins.2020.07.008","article-title":"How do sensory neurons sense danger signals?","volume":"43","author":"Donnelly","year":"2020","journal-title":"Trends Neurosci"},{"key":"2024030122262487900_awad339-B24","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/glia.21041","article-title":"Toll-like receptor expression in the peripheral nerve","volume":"58","author":"Goethals","year":"2010","journal-title":"Glia"},{"key":"2024030122262487900_awad339-B25","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/nn.2683","article-title":"Toll-like receptor 7 mediates pruritus","volume":"13","author":"Liu","year":"2010","journal-title":"Nat Neurosci"},{"key":"2024030122262487900_awad339-B26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.3881","article-title":"Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing","volume":"18","author":"Usoskin","year":"2015","journal-title":"Nat Neurosci"},{"key":"2024030122262487900_awad339-B27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/154405910608500108","article-title":"Trigeminal nociceptors express TLR-4 and CD14: A mechanism for pain due to infection","volume":"85","author":"Wadachi","year":"2006","journal-title":"J Dent Res"},{"key":"2024030122262487900_awad339-B28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/nm.3978","article-title":"Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade","volume":"21","author":"Xu","year":"2015","journal-title":"Nat Med"},{"key":"2024030122262487900_awad339-B29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","article-title":"Molecular architecture of the mouse nervous system","volume":"174","author":"Zeisel","year":"2018","journal-title":"Cell"},{"key":"2024030122262487900_awad339-B30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuron.2019.05.039","article-title":"Deep sequencing of somatosensory neurons reveals molecular determinants of intrinsic physiological properties","volume":"103","author":"Zheng","year":"2019","journal-title":"Neuron"},{"key":"2024030122262487900_awad339-B31","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1038\/srep15085","article-title":"HMGB1 induction of clustering creates a chemoresistant niche in human prostate tumor cells","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci Rep"},{"key":"2024030122262487900_awad339-B32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbi.2014.06.199","article-title":"Identification of a functional interaction of HMGB1 with receptor for advanced glycation end-products in a model of neuropathic pain","volume":"42","author":"Allette","year":"2014","journal-title":"Brain Behav Immun"},{"key":"2024030122262487900_awad339-B33","doi-asserted-by":"crossref","first-page":"jcs215939","DOI":"10.1242\/jcs.215939","article-title":"Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions","volume":"131","author":"Bestall","year":"2018","journal-title":"J Cell Sci"},{"key":"2024030122262487900_awad339-B34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejphar.2016.06.039","article-title":"Pattern recognition receptors in chronic pain: Mechanisms and therapeutic implications","volume":"788","author":"Kato","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"2024030122262487900_awad339-B35","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpain.2014.04.001","article-title":"Toll-like receptor 4 signaling contributes to paclitaxel-induced peripheral neuropathy","volume":"15","author":"Li","year":"2014","journal-title":"J Pain"},{"key":"2024030122262487900_awad339-B36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.expneurol.2013.08.018","article-title":"Receptor for advanced glycation end-products (RAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons","volume":"249","author":"Saleh","year":"2013","journal-title":"Exp Neurol"},{"key":"2024030122262487900_awad339-B37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2006-0073","article-title":"Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress","volume":"148","author":"Vincent","year":"2007","journal-title":"Endocrinology"},{"key":"2024030122262487900_awad339-B38","doi-asserted-by":"crossref","first-page":"e56886","DOI":"10.1371\/journal.pone.0056886","article-title":"The role of TLR4 in the paclitaxel effects on neuronal growth in vitro","volume":"8","author":"Ustinova","year":"2013","journal-title":"PLoS One"},{"key":"2024030122262487900_awad339-B39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-019-1581-6","article-title":"Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin\/thrombomodulin system in rodents: Negative impact of anticoagulants","volume":"16","author":"Tsubota","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2024030122262487900_awad339-B40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/cncr.27732","article-title":"Clinical pattern and associations of oxaliplatin acute neurotoxicity: A prospective study in 170 patients with colorectal cancer","volume":"119","author":"Argyriou","year":"2013","journal-title":"Cancer"},{"key":"2024030122262487900_awad339-B41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pain.2009.09.003","article-title":"Oxaliplatin-induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia","volume":"147","author":"Sakurai","year":"2009","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"2024030122262487900_awad339-B43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.040","article-title":"Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk","volume":"141","author":"Sekiguchi","year":"2018","journal-title":"Neuropharmacology"},{"key":"2024030122262487900_awad339-B44","doi-asserted-by":"crossref","first-page":"113121","DOI":"10.1016\/j.expneurol.2019.113121","article-title":"Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems","volume":"324","author":"Staff","year":"2020","journal-title":"Exp Neurol"},{"key":"2024030122262487900_awad339-B45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpain.2009.07.001","article-title":"Bortezomib-induced painful neuropathy in rats: A behavioral, neurophysiological and pathological study in rats","volume":"14","author":"Meregalli","year":"2010","journal-title":"Eur J Pain"},{"key":"2024030122262487900_awad339-B46","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.3390\/cells10102550","article-title":"Caspase-dependent HMGB1 release from macrophages participates in peripheral neuropathy caused by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice","volume":"10","author":"Tsubota","year":"2021","journal-title":"Cells"},{"key":"2024030122262487900_awad339-B47","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/ijms22020888","article-title":"Pathological mechanisms of bortezomib-induced peripheral neuropathy","volume":"22","author":"Yamamoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024030122262487900_awad339-B48","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1523\/JNEUROSCI.0966-19.2019","article-title":"Role of nociceptor toll-like receptor 4 (TLR4) in opioid-induced hyperalgesia and hyperalgesic priming","volume":"39","author":"Araldi","year":"2019","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B49","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1523\/JNEUROSCI.1673-15.2015","article-title":"Repeated mu-opioid exposure induces a novel form of the hyperalgesic priming model for transition to chronic pain","volume":"35","author":"Araldi","year":"2015","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B50","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/j.pain.0000000000000898","article-title":"Hyperalgesic priming (type II) induced by repeated opioid exposure: Maintenance mechanisms","volume":"158","author":"Araldi","year":"2017","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2018.10.015","article-title":"Mu-opioid receptor (MOR) biased agonists induce biphasic dose-dependent hyperalgesia and analgesia, and hyperalgesic priming in the rat","volume":"394","author":"Araldi","year":"2018","journal-title":"Neuroscience"},{"key":"2024030122262487900_awad339-B52","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1523\/JNEUROSCI.3476-17.2018","article-title":"Fentanyl induces rapid onset hyperalgesic priming: Type I at peripheral and type II at central nociceptor terminals","volume":"38","author":"Araldi","year":"2018","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0306-4522(89)90280-7","article-title":"Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system","volume":"32","author":"Taiwo","year":"1989","journal-title":"Neuroscience"},{"key":"2024030122262487900_awad339-B54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0006-8993(89)90928-1","article-title":"Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat","volume":"492","author":"Taiwo","year":"1989","journal-title":"Brain Res"},{"key":"2024030122262487900_awad339-B55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1523\/JNEUROSCI.1691-21.2021","article-title":"Neuroendocrine stress axis-dependence of duloxetine analgesia (anti-hyperalgesia) in chemotherapy-induced peripheral neuropathy","volume":"42","author":"Staurengo-Ferrari","year":"2022","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B56","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/j.pain.0000000000002073","article-title":"Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy","volume":"162","author":"Staurengo-Ferrari","year":"2021","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B57","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/j.pain.0000000000001798","article-title":"Marked sexual dimorphism in neuroendocrine mechanisms for the exacerbation of paclitaxel-induced painful peripheral neuropathy by stress","volume":"161","author":"Ferrari","year":"2020","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B58","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00280-007-0424-9","article-title":"Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14 C-bortezomib","volume":"60","author":"Hemeryck","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"2024030122262487900_awad339-B59","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.3390\/cancers13195013","article-title":"Reversal of bortezomib-induced neurotoxicity by suvecaltamide, a selective T-type Ca-channel modulator, in preclinical models","volume":"13","author":"Meregalli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2024030122262487900_awad339-B60","doi-asserted-by":"crossref","first-page":"H2059","DOI":"10.1152\/ajpheart.00445.2009","article-title":"Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process","volume":"297","author":"Xu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024030122262487900_awad339-B61","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/j.pain.0000000000000936","article-title":"Nociceptor interleukin 10 receptor 1 is critical for muscle analgesia induced by repeated bouts of eccentric exercise in the rat","volume":"158","author":"Alvarez","year":"2017","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pain.2007.05.012","article-title":"Proinflammatory cytokines mediating burn-injury pain","volume":"135","author":"Summer","year":"2008","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1523\/JNEUROSCI.2160-20.2020","article-title":"Opioid-Induced hyperalgesic priming in single nociceptors","volume":"41","author":"Khomula","year":"2021","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B64","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1523\/JNEUROSCI.1189-21.2021","article-title":"PI3K\u03b3\/AKT signaling in high molecular weight hyaluronan (HMWH)-induced anti-hyperalgesia and reversal of nociceptor sensitization","volume":"41","author":"Bonet","year":"2021","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B65","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0306-4522(95)00433-5","article-title":"Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro","volume":"71","author":"Gold","year":"1996","journal-title":"Neuroscience"},{"key":"2024030122262487900_awad339-B66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.1985.sp015573","article-title":"Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones","volume":"359","author":"Harper","year":"1985","journal-title":"J Physiol"},{"key":"2024030122262487900_awad339-B67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0306-4522(02)00409-8","article-title":"Chemical responsiveness and histochemical phenotype of electrophysiologically classified cells of the adult rat dorsal root ganglion","volume":"115","author":"Petruska","year":"2002","journal-title":"Neuroscience"},{"key":"2024030122262487900_awad339-B68","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1152\/jn.2000.84.5.2365","article-title":"Subclassified acutely dissociated cells of rat DRG: Histochemistry and patterns of capsaicin-, proton-, and ATP-activated currents","volume":"84","author":"Petruska","year":"2000","journal-title":"J Neurophysiol"},{"key":"2024030122262487900_awad339-B69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuron.2007.07.016","article-title":"Nociceptors--noxious stimulus detectors","volume":"55","author":"Woolf","year":"2007","journal-title":"Neuron"},{"key":"2024030122262487900_awad339-B70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1523\/JNEUROSCI.2695-17.2017","article-title":"CD44 signaling mediates high molecular weight hyaluronan-induced antihyperalgesia","volume":"38","author":"Ferrari","year":"2018","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B71","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1523\/JNEUROSCI.1191-19.2019","article-title":"In vitro nociceptor neuroplasticity associated with in vivo opioid-induced hyperalgesia","volume":"39","author":"Khomula","year":"2019","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12990-015-0028-z","article-title":"Upregulation of T-type Ca2+ channels in long-term diabetes determines increased excitability of a specific type of capsaicin-insensitive DRG neurons","volume":"11","author":"Duzhyy","year":"2015","journal-title":"Mol Pain"},{"key":"2024030122262487900_awad339-B73","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2016.10.011","article-title":"Mechanical sensitivity and electrophysiological properties of acutely dissociated dorsal root ganglion neurons of rats","volume":"634","author":"Viatchenko-Karpinski","year":"2016","journal-title":"Neurosci Lett"},{"key":"2024030122262487900_awad339-B74","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw"},{"key":"2024030122262487900_awad339-B75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2008.08.005","article-title":"Sexual dimorphism in the effect of sound stress on neutrophil function","volume":"205","author":"Brown","year":"2008","journal-title":"J Neuroimmunol"},{"key":"2024030122262487900_awad339-B76","doi-asserted-by":"crossref","first-page":"31221","DOI":"10.1038\/srep31221","article-title":"Marked sexual dimorphism in the role of the ryanodine receptor in a model of pain chronification in the rat","volume":"6","author":"Ferrari","year":"2016","journal-title":"Sci Rep"},{"key":"2024030122262487900_awad339-B77","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0306-4522(03)00203-3","article-title":"Sexual dimorphism for protein kinase c epsilon signaling in a rat model of vincristine-induced painful peripheral neuropathy","volume":"119","author":"Joseph","year":"2003","journal-title":"Neuroscience"},{"key":"2024030122262487900_awad339-B78","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1523\/JNEUROSCI.2911-16.2017","article-title":"Sexual dimorphism in a reciprocal interaction of ryanodine and IP(3) receptors in the induction of hyperalgesic priming","volume":"37","author":"Khomula","year":"2017","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B79","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1523\/JNEUROSCI.3257-18.2019","article-title":"Macrophage toll-like receptor 9 contributes to chemotherapy-induced neuropathic pain in male mice","volume":"39","author":"Luo","year":"2019","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B80","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.12688\/f1000research.8053.1","article-title":"Chemotherapy-induced peripheral neuropathy: An update on the current understanding","volume":"5","author":"Addington","year":"2016","journal-title":"F1000Res"},{"key":"2024030122262487900_awad339-B81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000499599","article-title":"Prevention and management of chemotherapy-induced polyneuropathy","volume":"14","author":"Jordan","year":"2019","journal-title":"Breast Care (Basel)"},{"key":"2024030122262487900_awad339-B82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.critrevonc.2015.04.011","article-title":"Taxane induced neuropathy in patients affected by breast cancer: Literature review","volume":"96","author":"De Iuliis","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"2024030122262487900_awad339-B83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/96.1.69","article-title":"Vincristine neuropathy. Clinical and electrophysiological observations","volume":"96","author":"Casey","year":"1973","journal-title":"Brain"},{"key":"2024030122262487900_awad339-B84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01050259","article-title":"Long-term effects of vincristine on the peripheral nervous system","volume":"15","author":"Postma","year":"1993","journal-title":"J Neurooncol"},{"key":"2024030122262487900_awad339-B85","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/1096-9861(20000904)424:4<563::AID-CNE1>3.0.CO;2-U","article-title":"Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat","volume":"424","author":"Topp","year":"2000","journal-title":"J Comp Neurol"},{"key":"2024030122262487900_awad339-B86","first-page":"435","article-title":"Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents","volume":"15","author":"Argyriou","year":"2010","journal-title":"J BUON"},{"key":"2024030122262487900_awad339-B87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/annonc\/mdq676","article-title":"Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: How significant is peripheral neuropathy?","volume":"22","author":"Arkenau","year":"2011","journal-title":"Ann Oncol"},{"key":"2024030122262487900_awad339-B88","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2010-0248","article-title":"Long-term neuropathy after oxaliplatin treatment: Challenging the dictum of reversibility","volume":"16","author":"Park","year":"2011","journal-title":"Oncologist"},{"key":"2024030122262487900_awad339-B89","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1188\/11.CJON.182-188","article-title":"Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin","volume":"15","author":"Tofthagen","year":"2011","journal-title":"Clin J Oncol Nurs"},{"key":"2024030122262487900_awad339-B90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp Neurol"},{"key":"2024030122262487900_awad339-B91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SPC.0b013e328342f9cc","article-title":"Chemotherapy-induced neuropathic pain","volume":"5","author":"Farquhar-Smith","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"2024030122262487900_awad339-B92","first-page":"128","article-title":"Bortezomib-induced polyneuropathy","volume":"71","author":"Rampen","year":"2013","journal-title":"Neth J Med"},{"key":"2024030122262487900_awad339-B93","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1212\/WNL.62.12.2291","article-title":"Thalidomide sensory neurotoxicity: A clinical and neurophysiologic study","volume":"62","author":"Cavaletti","year":"2004","journal-title":"Neurology"},{"key":"2024030122262487900_awad339-B94","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2174\/092986708786848569","article-title":"Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies","volume":"15","author":"Park","year":"2008","journal-title":"Curr Med Chem"},{"key":"2024030122262487900_awad339-B95","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jpainsymman.2011.02.022","article-title":"Epothilone-induced peripheral neuropathy: A review of current knowledge","volume":"42","author":"Argyriou","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"2024030122262487900_awad339-B96","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1007\/s00520-012-1384-0","article-title":"Ixabepilone-associated peripheral neuropathy: Data from across the phase II and III clinical trials","volume":"20","author":"Vahdat","year":"2012","journal-title":"Support Care Cancer"},{"key":"2024030122262487900_awad339-B97","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"2024030122262487900_awad339-B98","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/10781552211052646","article-title":"Evaluating the effects of duloxetine on prophylaxis of oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: A randomized double-blind placebo controlled clinical trial","volume":"29","author":"Rokhsareh","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"2024030122262487900_awad339-B99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13046-021-02141-z","article-title":"Targeting strategies for oxaliplatin-induced peripheral neuropathy: Clinical syndrome, molecular basis, and drug development","volume":"40","author":"Yang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"2024030122262487900_awad339-B100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/j.seminoncol.2021.09.004","article-title":"Chemotherapy-induced peripheral neuropathy and rehabilitation: A review","volume":"48","author":"Zhang","year":"2021","journal-title":"Semin Oncol"},{"key":"2024030122262487900_awad339-B101","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2147\/JPR.S213912","article-title":"Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: From pain relief towards disease modification","volume":"12","author":"Anand","year":"2019","journal-title":"J Pain Res"},{"key":"2024030122262487900_awad339-B102","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00280-018-3664-y","article-title":"Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy","volume":"82","author":"Farshchian","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"2024030122262487900_awad339-B103","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.0000000000007974","article-title":"Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic review","volume":"93","author":"Gewandter","year":"2019","journal-title":"Neurology"},{"key":"2024030122262487900_awad339-B104","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10147-015-0810-y","article-title":"Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: A pilot randomized trial","volume":"20","author":"Hirayama","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"2024030122262487900_awad339-B105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12032-017-0995-1","article-title":"Predictors of the usefulness of duloxetine for chemotherapy-induced peripheral neuropathy","volume":"34","author":"Kanbayashi","year":"2017","journal-title":"Med Oncol"},{"key":"2024030122262487900_awad339-B106","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jpainsymman.2019.06.020","article-title":"Additive duloxetine for cancer-related neuropathic pain nonresponsive or intolerant to opioid-pregabalin therapy: A randomized controlled trial (JORTC-PAL08)","volume":"58","author":"Matsuoka","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2024030122262487900_awad339-B107","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00432-020-03216-8","article-title":"Long-term small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia after stem cell transplantation","volume":"146","author":"Ruscher","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"2024030122262487900_awad339-B108","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"2024030122262487900_awad339-B109","doi-asserted-by":"crossref","first-page":"e18653","DOI":"10.1097\/MD.0000000000018653","article-title":"Effect of serotonin-norepinephrine reuptake inhibitors for patients with chemotherapy-induced painful peripheral neuropathy: A meta-analysis","volume":"99","author":"Song","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 2","key":"2024030122262487900_awad339-B110","first-page":"S40","article-title":"Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment","volume":"24","author":"Tamburin","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"2024030122262487900_awad339-B111","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpain.2019.06.011","article-title":"Quantification of small fiber neuropathy in chemotherapy-treated patients","volume":"21","author":"Timmins","year":"2020","journal-title":"J Pain"},{"key":"2024030122262487900_awad339-B112","doi-asserted-by":"crossref","first-page":"135941","DOI":"10.1016\/j.neulet.2021.135941","article-title":"Role of innate immunity in chemotherapy-induced peripheral neuropathy","volume":"755","author":"Uhelski","year":"2021","journal-title":"Neurosci Lett"},{"key":"2024030122262487900_awad339-B113","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pain.2010.10.030","article-title":"Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline","volume":"152","author":"Boyette-Davis","year":"2011","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2012.03.027","article-title":"Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy","volume":"59","author":"Wang","year":"2012","journal-title":"Cytokine"},{"key":"2024030122262487900_awad339-B115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11910-003-0043-8","article-title":"Medication-induced peripheral neuropathy","volume":"3","author":"Weimer","year":"2003","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2024030122262487900_awad339-B116","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2006.01.037","article-title":"Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction","volume":"122","author":"Flatters","year":"2006","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B117","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","article-title":"Chemotherapy-induced neuropathy","volume":"13","author":"Windebank","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"2024030122262487900_awad339-B118","doi-asserted-by":"crossref","first-page":"642420","DOI":"10.3389\/fimmu.2021.642420","article-title":"Neuroimmune consequences of eIF4E phosphorylation on chemotherapy-induced peripheral neuropathy","volume":"12","author":"Agalave","year":"2021","journal-title":"Front Immunol"},{"issue":"3 Suppl","key":"2024030122262487900_awad339-B119","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/00002508-200009001-00005","article-title":"A neuroimmune interaction in painful peripheral neuropathy","volume":"16","author":"Bennett","year":"2000","journal-title":"Clin J Pain"},{"key":"2024030122262487900_awad339-B120","doi-asserted-by":"crossref","first-page":"626687","DOI":"10.3389\/fimmu.2020.626687","article-title":"Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy","volume":"11","author":"Fumagalli","year":"2020","journal-title":"Front Immunol"},{"key":"2024030122262487900_awad339-B121","doi-asserted-by":"crossref","first-page":"68","DOI":"10.12688\/wellcomeopenres.16635.1","article-title":"Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability","volume":"6","author":"Hore","year":"2021","journal-title":"Wellcome Open Res"},{"key":"2024030122262487900_awad339-B122","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/j.pain.0000000000002454","article-title":"Dorsal root ganglion toll-like receptor 4 signaling contributes to oxaliplatin-induced peripheral neuropathy","volume":"163","author":"Illias","year":"2022","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B123","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2014.08.010","article-title":"Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy","volume":"44","author":"Janes","year":"2015","journal-title":"Brain Behav Immun"},{"key":"2024030122262487900_awad339-B124","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.12.006","article-title":"Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy","volume":"73","author":"Lees","year":"2017","journal-title":"Eur J Cancer"},{"key":"2024030122262487900_awad339-B125","doi-asserted-by":"crossref","first-page":"660203","DOI":"10.3389\/fimmu.2021.660203","article-title":"Cutaneous neuroimmune interactions in peripheral neuropathic pain states","volume":"12","author":"Lowy","year":"2021","journal-title":"Front Immunol"},{"key":"2024030122262487900_awad339-B126","doi-asserted-by":"crossref","first-page":"12042","DOI":"10.1016\/S0021-9258(18)67199-6","article-title":"Hydroxyl\/bile acid exchange. A new mechanism for the uphill transport of cholate by basolateral liver plasma membrane vesicles","volume":"261","author":"Blitzer","year":"1986","journal-title":"J Biol Chem"},{"key":"2024030122262487900_awad339-B127","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-immunol-041015-055340","article-title":"Neuroimmunity: Physiology and pathology","volume":"34","author":"Talbot","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"2024030122262487900_awad339-B128","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1523\/JNEUROSCI.17-20-08018.1997","article-title":"Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat","volume":"17","author":"Aley","year":"1997","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(98)00738-1","article-title":"A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat","volume":"256","author":"Khasar","year":"1998","journal-title":"Neurosci Lett"},{"key":"2024030122262487900_awad339-B130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/j.pain.0000000000002828","article-title":"Neuroendocrine mechanisms in oxaliplatin-induced hyperalgesic priming","volume":"164","author":"Staurengo-Ferrari","year":"2023","journal-title":"Pain"},{"key":"2024030122262487900_awad339-B131","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1096\/fj.202002136R","article-title":"The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways","volume":"34","author":"Prantner","year":"2020","journal-title":"FASEB J"},{"key":"2024030122262487900_awad339-B132","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molimm.2013.07.008","article-title":"RAGE and TLRs: Relatives, friends or neighbours?","volume":"56","author":"Ibrahim","year":"2013","journal-title":"Mol Immunol"},{"key":"2024030122262487900_awad339-B133","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.1900860","article-title":"Interplay between RAGE and TLR4 regulates HMGB1-induced inflammation by promoting cell surface expression of RAGE and TLR4","volume":"205","author":"Zhong","year":"2020","journal-title":"J Immunol"},{"key":"2024030122262487900_awad339-B134","first-page":"1273","article-title":"Early release of soluble receptor for advanced glycation endproducts after severe trauma in humans","volume":"68","author":"Cohen","year":"2010","journal-title":"J Trauma"},{"key":"2024030122262487900_awad339-B135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1590\/1678-775720130593","article-title":"Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: Role of p38 MAPK and NF-KB","volume":"22","author":"Medeiros","year":"2014","journal-title":"J Appl Oral Sci"},{"key":"2024030122262487900_awad339-B136","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"2024030122262487900_awad339-B137","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/carcin\/bgr101","article-title":"Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1\/2 and Akt and nuclear translocation of NF-kappaB","volume":"32","author":"Tafani","year":"2011","journal-title":"Carcinogenesis"},{"key":"2024030122262487900_awad339-B138","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","article-title":"S100 proteins as an important regulator of macrophage inflammation","volume":"8","author":"Xia","year":"2017","journal-title":"Front Immunol"},{"key":"2024030122262487900_awad339-B139","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1159\/000495651","article-title":"Ectodomain shedding of RAGE and TLR4 as a negative feedback regulation in high-mobility group box 1-activated aortic endothelial cells","volume":"51","author":"Yang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2024030122262487900_awad339-B140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/cells9020383","article-title":"Impact of HMGB1, RAGE, and TLR4 in Alzheimer\u2019s disease (AD): From risk factors to therapeutic targeting","volume":"9","author":"Paudel","year":"2020","journal-title":"Cells"},{"key":"2024030122262487900_awad339-B141","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1113\/JP273455","article-title":"Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons","volume":"595","author":"Chakraborty","year":"2017","journal-title":"J Physiol"},{"key":"2024030122262487900_awad339-B142","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1471-4159.2012.07920.x","article-title":"Ca++\/CaMKII switches nociceptor-sensitizing stimuli into desensitizing stimuli","volume":"123","author":"Hucho","year":"2012","journal-title":"J Neurochem"},{"key":"2024030122262487900_awad339-B143","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpain.2013.12.005","article-title":"Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat","volume":"15","author":"Ferrari","year":"2014","journal-title":"J Pain"},{"key":"2024030122262487900_awad339-B144","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4161\/auto.20258","article-title":"AGER\/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6\u2013pSTAT3 pathway","volume":"8","author":"Kang","year":"2012","journal-title":"Autophagy"},{"key":"2024030122262487900_awad339-B145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2017.07.010","article-title":"Activation of RAGE\/STAT3 pathway by methylglyoxal contributes to spinal central sensitization and persistent pain induced by bortezomib","volume":"296","author":"Wei","year":"2017","journal-title":"Exp Neurol"},{"key":"2024030122262487900_awad339-B146","doi-asserted-by":"crossref","first-page":"e75804","DOI":"10.1371\/journal.pone.0075804","article-title":"Stat3 inhibition attenuates mechanical allodynia through transcriptional regulation of chemokine expression in spinal astrocytes","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"2024030122262487900_awad339-B147","doi-asserted-by":"crossref","first-page":"172880","DOI":"10.1016\/j.ejphar.2019.172880","article-title":"LncRNAs linc00311 and AK141205 are identified as new regulators in STAT3-mediated neuropathic pain in bCCI rats","volume":"868","author":"Pang","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"2024030122262487900_awad339-B148","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1523\/JNEUROSCI.6343-11.2012","article-title":"Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain","volume":"32","author":"Doyle","year":"2012","journal-title":"J Neurosci"},{"key":"2024030122262487900_awad339-B149","doi-asserted-by":"crossref","first-page":"e25212","DOI":"10.1371\/journal.pone.0025212","article-title":"Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy","volume":"6","author":"Fidanboylu","year":"2011","journal-title":"PLoS One"},{"key":"2024030122262487900_awad339-B150","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.4049\/jimmunol.172.4.2522","article-title":"Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B","volume":"172","author":"Asehnoune","year":"2004","journal-title":"J Immunol"},{"key":"2024030122262487900_awad339-B151","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/leu.2010.225","article-title":"HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells","volume":"25","author":"Liu","year":"2011","journal-title":"Leukemia"},{"key":"2024030122262487900_awad339-B152","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1742-2094-9-180","article-title":"The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain","volume":"9","author":"Feldman","year":"2012","journal-title":"J Neuroinflammation"},{"key":"2024030122262487900_awad339-B153","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-019-0657-y","article-title":"Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth","volume":"7","author":"Cerles","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"2024030122262487900_awad339-B154","doi-asserted-by":"crossref","first-page":"111185","DOI":"10.1016\/j.biopha.2020.111185","article-title":"Suppression of delayed rectifier K(+) channels by gentamicin induces membrane hyperexcitability through JNK and PKA signaling pathways in vestibular ganglion neurons","volume":"135","author":"Zhang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2024030122262487900_awad339-B155","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3390\/ijms20122904","article-title":"Chemokine signaling in chemotherapy-induced neuropathic pain","volume":"20","author":"Brandolini","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024030122262487900_awad339-B156","doi-asserted-by":"crossref","first-page":"1015746","DOI":"10.3389\/fmolb.2022.1015746","article-title":"Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients","volume":"9","author":"Tay","year":"2022","journal-title":"Front Mol Biosci"},{"key":"2024030122262487900_awad339-B157","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1533-2500.2010.00367.x","article-title":"The role of glia and the immune system in the development and maintenance of neuropathic pain","volume":"10","author":"Vallejo","year":"2010","journal-title":"Pain Pract"},{"key":"2024030122262487900_awad339-B158","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jpain.2016.02.011","article-title":"Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy-induced peripheral neuropathy","volume":"17","author":"Zhang","year":"2016","journal-title":"J Pain"},{"key":"2024030122262487900_awad339-B159","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","article-title":"The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines","volume":"229","author":"Austin","year":"2010","journal-title":"J Neuroimmunol"},{"key":"2024030122262487900_awad339-B160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbi.2014.03.014","article-title":"CX3CL1-mediated macrophage activation contributed to paclitaxel-induced DRG neuronal apoptosis and painful peripheral neuropathy","volume":"40","author":"Huang","year":"2014","journal-title":"Brain Behav Immun"},{"key":"2024030122262487900_awad339-B161","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: Neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci"},{"key":"2024030122262487900_awad339-B162","doi-asserted-by":"crossref","first-page":"1744806917714693","DOI":"10.1177\/1744806917714693","article-title":"Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?","volume":"13","author":"Aromolaran","year":"2017","journal-title":"Mol Pain"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awad339\/56725645\/awad339.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/3\/1025\/56816832\/awad339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/3\/1025\/56816832\/awad339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T22:31:54Z","timestamp":1709332314000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/147\/3\/1025\/7287981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":162,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,10,3]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awad339","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,10,3]]}}}